Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Inventory (2016 - 2025)

Amphastar Pharmaceuticals has reported Change in Inventory over the past 13 years, most recently at -$9.0 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$9.0 million for Q4 2025, down 136.82% from a year ago — trailing twelve months through Dec 2025 was $21.1 million (down 56.84% YoY), and the annual figure for FY2025 was $21.1 million, down 56.84%.
  • Change in Inventory for Q4 2025 was -$9.0 million at Amphastar Pharmaceuticals, down from -$5.9 million in the prior quarter.
  • Over the last five years, Change in Inventory for AMPH hit a ceiling of $31.1 million in Q1 2025 and a floor of -$9.0 million in Q4 2025.
  • Median Change in Inventory over the past 5 years was $3.4 million (2021), compared with a mean of $4.1 million.
  • Biggest five-year swings in Change in Inventory: plummeted 309.27% in 2023 and later soared 3829.48% in 2024.
  • Amphastar Pharmaceuticals' Change in Inventory stood at -$7.0 million in 2021, then surged by 83.26% to -$1.2 million in 2022, then crashed by 309.27% to -$4.8 million in 2023, then soared by 608.37% to $24.5 million in 2024, then crashed by 136.82% to -$9.0 million in 2025.
  • The last three reported values for Change in Inventory were -$9.0 million (Q4 2025), -$5.9 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.